The requirements for quality data in drug registration with the MFDS include comprehensive documentation of manufacturing processes, control measures, and product specifications. Data must demonstrate consistent quality, stability, and purity of the drug. Additionally, compliance with Good Manufacturing Practices (GMP) and detailed reporting on raw materials and quality testing are essential.